Skip to content
★ Sign in to follow
OB
Total declarations
48
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (31 ops.)
€6.5M

Latest filing published 02 Mar 2010 for Abbott Laboratories.

Insider track record

Disclosed buys
0
Disclosed sells
31
Signal history

No signal scores available.

Olivier Bohuon: trading record in brief

Olivier Bohuon appears in our data through filings on Abbott Laboratories shares, published by SEC (Form 4). Between 17 February 2007 and 26 February 2010, the trades on record add up to 48 filings.

Sales make up the whole of the open-market record (31 sales, €6.5M). The rest of the record consists of 12 share grants and 5 option exercises. Since January 2010: no purchases and 18 sales on the market.

The latest filing, published on 2 March 2010, reports a share grant in Abbott Laboratories. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Olivier Bohuon

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations43 total
  • ◆
    Executive Vice PresidentExecutivesAbbott Laboratories
    0SEC
    26,667 shares0Common shares without par valueSEC:0001179110-10-004240:0
  • ▼
    Executive Vice PresidentExecutivesAbbott Laboratories
    197,399 USD0SEC
    3,634 shares@ US$54.32Common shares without par valueSEC:0001179110-10-004240:1
  • ▼
    Executive Vice PresidentExecutivesAbbott Laboratories
    5,432 USD0SEC
    100 shares@ US$54.32Common shares without par valueSEC:0001179110-10-004240:2
  • ▼
    Executive Vice PresidentExecutivesAbbott Laboratories
    21,728 USD0SEC
    400 shares@ US$54.32Common shares without par valueSEC:0001179110-10-004240:3
  • ▼
    Executive Vice PresidentExecutivesAbbott Laboratories
    65,184 USD0SEC
    1,200 shares@ US$54.32Common shares without par valueSEC:0001179110-10-004240:4
  • ▼
    Executive Vice PresidentExecutivesAbbott Laboratories
    190,155 USD0SEC
    3,500 shares@ US$54.33Common shares without par valueSEC:0001179110-10-004240:5
  • ▼
    Executive Vice PresidentExecutivesAbbott Laboratories
    16,299 USD0SEC
    300 shares@ US$54.33Common shares without par valueSEC:0001179110-10-004240:6
  • ▼
    Executive Vice PresidentExecutivesAbbott Laboratories
    5,433 USD0SEC
    100 shares@ US$54.33Common shares without par valueSEC:0001179110-10-004240:7
  • ▼
    Executive Vice PresidentExecutivesAbbott Laboratories
    59,763 USD0SEC
    1,100 shares@ US$54.33Common shares without par valueSEC:0001179110-10-004240:8
  • ▼
    Executive Vice PresidentExecutivesAbbott Laboratories
    141,258 USD0SEC
    2,600 shares@ US$54.33Common shares without par valueSEC:0001179110-10-004240:11
  • ▼
    Executive Vice PresidentExecutivesAbbott Laboratories
    10,866 USD0SEC
    200 shares@ US$54.33Common shares without par valueSEC:0001179110-10-004240:12
  • ◆
    Executive Vice PresidentExecutivesAbbott Laboratories
    0SEC
    32,000 shares0Common shares without par valueSEC:0001179110-10-003599:0
  • ◆
    Executive Vice PresidentExecutivesAbbott Laboratories
    0SEC
    17,000 shares0Common shares without par valueSEC:0001179110-10-003133:0
  • ▼
    Executive Vice PresidentExecutivesAbbott Laboratories
    125,097 USD0SEC
    2,300 shares@ US$54.39Common shares without par valueSEC:0001179110-10-003133:1
  • ▼
    Executive Vice PresidentExecutivesAbbott Laboratories
    5,439 USD0SEC
    100 shares@ US$54.39Common shares without par valueSEC:0001179110-10-003133:2
  • ▼
    Executive Vice PresidentExecutivesAbbott Laboratories
    331,779 USD0SEC
    6,100 shares@ US$54.39Common shares without par valueSEC:0001179110-10-003133:3
  • ◇
    Executive Vice PresidentExecutivesAbbott Laboratories
    2M USD0SEC
    34,800 shares@ US$46.34Common shares without par valueSEC:0001179110-09-015487:0
  • ◇
    Executive Vice PresidentExecutivesAbbott Laboratories
    2M USD0SEC
    36,000 shares@ US$44.16Common shares without par valueSEC:0001179110-09-015487:1
  • ▼
    Executive Vice PresidentExecutivesAbbott Laboratories
    26,620 USD0SEC
    500 shares@ US$53.24Common shares without par valueSEC:0001179110-09-015487:2
  • ▼
    Executive Vice PresidentExecutivesAbbott Laboratories
    10,652 USD0SEC
    200 shares@ US$53.26Common shares without par valueSEC:0001179110-09-015487:3
  • ▼
    Executive Vice PresidentExecutivesAbbott Laboratories
    410,025 USD0SEC
    7,700 shares@ US$53.25Common shares without par valueSEC:0001179110-09-015487:4
  • ▼
    Executive Vice PresidentExecutivesAbbott Laboratories
    825,530 USD0SEC
    15,500 shares@ US$53.26Common shares without par valueSEC:0001179110-09-015487:5
  • ▼
    Executive Vice PresidentExecutivesAbbott Laboratories
    793,723 USD0SEC
    14,900 shares@ US$53.27Common shares without par valueSEC:0001179110-09-015487:6
  • ▼
    Executive Vice PresidentExecutivesAbbott Laboratories
    1M USD0SEC
    21,800 shares@ US$53.28Common shares without par valueSEC:0001179110-09-015487:7
  • ▼
    Executive Vice PresidentExecutivesAbbott Laboratories
    820,666 USD0SEC
    15,400 shares@ US$53.29Common shares without par valueSEC:0001179110-09-015487:8

25 of 43 declarations